• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2000375 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2020-08-10 Sanofi SpA;Sanofi-Aventis Groupe Filed 2020-08-17 view
JYSB2000091 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2020-04-02 Sanofi SpA;Sanofi-Aventis Groupe Certificate Issued 2020-07-16 view
JYSB2000092 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2020-03-26 Sanofi SpA;Sanofi-Aventis Groupe Certificate Issued 2020-07-16 view
JYSB2000012 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2020-02-10 Sanofi SpA;Sanofi-Aventis Groupe Certificate Issued 2020-04-08 view
JYSB1900074 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2019-04-01 Sanofi SpA;Sanofi-Aventis Groupe Certificate Issued 2019-06-03 view
JYSB1900073 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2019-04-15 Sanofi SpA;Sanofi-Aventis Groupe Certificate Issued 2019-06-03 view
JYSF1800017 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2018-11-26 Sanofi SpA;Sanofi-Aventis Groupe Certificate Issued 2018-12-18 view
JYSB1800244 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2018-11-23 Sanofi SpA;Sanofi-Aventis Groupe Certificate Issued 2018-12-18 view
JYSB1700094 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2017-06-01 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Sanofi SpA;Sanofi-Aventis Groupe Certificate Issued 2018-10-26 view
JXSS1600009 注射用拉布立海 rasburicase Lyophilized Biological Products Import Drug Application 2017-01-13 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Sanofi SpA;Sanofi-Aventis Groupe Certificate Issued 2018-10-26 view
JXHL1300051 注射用拉布立海 rasburicase Lyophilized Chemical Drugs Import Drug Application 2013-02-20 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Sanofi-Aventis Groupe Certificate Issued 2016-08-08 view
JXHS1000026 注射用拉布立海 rasburicase Lyophilized Chemical Drugs Import Drug Application 2010-04-13 赛诺菲安万特(中国)投资有限公司 Sanofi (China) Investment Co Ltd;Glaxo Wellcome Production;Sanofi-Aventis Certificate Issued 2016-07-25 view
JYHB1301024 注射用拉布立海 rasburicase Lyophilized Chemical Drugs Supplementary Application 2013-09-26 Sanofi-aventis groupe Sanofi-Aventis Groupe;Sanofi-Aventis SpA Approval Completed-Pending Certificated 2014-09-25 view
JYHB0601067 注射用拉布立海 rasburicase Lyophilized Chemical Drugs Supplementary Application 2006-12-20 Sanofi-Aventis;Sanofi Winthrop Industrie Certificate Issued 2007-06-11 view
A20010109 注射用拉布立海 rasburicase Lyophilized Chemical Drugs New Drug Application 2004-05-11 法国赛诺菲圣德拉堡集团中国人公司北京办事处 Sanofi Saint Germain Group China Branch Beijing Office, France Certificate Issued 2004-04-09 view
JYSZ2200052 注射用拉布立海 rasburicase Lyophilized Biological Products License Renew 2022-10-10 Sanofi-Aventis Groupe;Sanofi Srl;Sanofi (China) Investment Co Ltd view
JYSB2300027 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2023-02-14 Sanofi-Aventis Groupe;Sanofi Srl view
JYSB2300028 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2023-02-14 Sanofi-Aventis Groupe;Sanofi Srl view
JYSB2200139 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2022-08-02 Sanofi-Aventis Groupe;Sanofi Srl view
JYSB2500080 注射用拉布立海 rasburicase Lyophilized Biological Products Supplementary Application 2025-03-26 Sanofi Srl;Sanofi Winthrop Industrie view